The prognostic significance of cerebrospinal fluid in multiple sclerosis

Journal of the Neurological Sciences

Volumn 279, Issue 1-2, 2009, Pages 21-25

  Siritho, Sasitorn ^a   Freedman, Mark S ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cerebrospinal fluid; Inflammation; Multiple Sclerosis; Oligoclonal banding; Prognosis; Relapsing

Indexed keywords

IMMUNOGLOBULIN G; OLIGOCLONAL BAND;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; BRAIN; CHILD; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPINAL CORD; YOUNG ADULT;

EID: 61449241679     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.12.029     Document Type: Article

References (38)

1. Poser C.M., Paty P.W., Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13 (1983) 227-231
2. Polman C.H., Reingold S.C., and Edan G. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald criteria. Ann Neurol 58 6 (2005) 840-846
3. Bourahoui A., De Seze J., and Guttierez R. CSF isoelectrofocusing in a large cohort of MS and other neurological diseases. Eur J Neurol 11 (2004) 525-529
4. Farrell M.A., Kaufmann J.C.E., Gilbert J.J., et al. Oligoclonal bands in multiple sclerosis : clinicopathologic correlation. Neurology 35 (1985) 212-218
5. Poser C.M., and Brinar V.V. The accuracy of prevalence rates of multiple sclerosis: a critical review. Neuroepidemiology 29 3-4 (2007) 150-155
6. Kuroiwa Y., Hung T.P., Landsborough D., Park C.S., and Signhal B.S. Multiple sclerosis in Asia. Neurology 27 (1997) 188-192
7. Stendahl-Brodin L., and Link H. Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid. J Neurol Neurosurg Psychiatry 43 (1980) 102-105
8. Zeman A.Z., Kidd D., McLean B.N., et al. A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry 60 (1996) 27-30
9. Annunziata P., Giorgio A., De Santi L., et al. Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-β. J Neurol Sci 244 (2006) 97-102
10. Electronic Multiple Sclerosis Monitor System (Imed 4.6) Software Program Serono International SA. Copyright 2006.
11. Kurtzke J.F. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
12. Confavreux C., Vukusic S., Moreau T., et al. Relapses and progression of disability in multiple sclerosis. N Engl J Med 343 (2000) 1430-1438
13. Roburgh R.H., Seaman S.R., Masterman T., et al. Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology 64 (2005) 1144-1151
14. Lunding J., Midgrad R., and Vedeler C.A. Oligoclonal bands in cerebrospinal fluid: a comparative study of isoelectric focusing, agarose gel electrophoresis and IgG index. Acta Neurol Scand 102 (2000) 322-325
15. Hans L., and Yu-Min H. Oligocloal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol 180 (2006) 17-28
16. Freedman M.S., Thompson E.J., Deisenhammer F., et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis. Arch Neurol 62 (2005) 865-870
17. Barkhof F., Filippi M., and Miller D.H. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite MS. Brain 120 (1997) 2059-2069
18. Rodeghier M. Surveys with confidence: a practical guide to survey research using SPSS (1996), SPSS Inc.
19. Pirttila T., and Nurmikko T. CSF oligoclonal bands, MRI, and the diagnosis of multiple sclerosis. Acta Neurol Scand 92 6 (Dec 1995) 468-471
20. Jose M., Sequeira L., and Edite Rio M. Oligoclonal IgG bands in the cerebrospinal fluid of Portuguese patients with multiple sclerosis: negative results indicate benign disease. Arq Neuro-Psiquiatr 63 2b (2005) Sao Paulo June 2005
21. Kikuchi S., Fukazawa T., and Niio M. HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Neurology 60 (2003) 647-651
22. Nakashima I., Fujihara K., Misu T., et al. Significant correlation between IL-10 levels and IgG indices in the cerebrospinal fluid of patients with multiple sclerosis. J Neuroimmunol 111 1-2 (Nov 1 2000) 64-67
23. Avasarala J.R., Cross A.H., and Trotter J.L. Oligoclonal band number as a marker for prognosis in multiple sclerosis. Arch Neurol 58 (2001) 2044-2045
24. Fukazawa T., Kikuchi S., Sasaki H., et al. The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenic backgrounds. J Neurol Sci 158 2 (1998) 209-214
25. Imrell K., Landtblom A.M., Hillert J., et al. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 67 (2006) 1062-1064
26. Trojano M., Logroscino G.C., Pisicchio L., et al. The multiple sclerosis cooperative etiological study in Italy : preliminary analysis of CSF findings. Ital J Neurol Sci suppl 6 (1987) 71-76
27. Nakashima I., Fujihara K., and Misu T. A comparative study of Japanese multiple sclerosis patients with and without oligoclonal IgG bands. Mult Scler 8 (2002) 459-462
28. Nakashima I., Fujihara K., and Miyazawa H. Relevance of colossal and periventricular MRI lesions to oligoclonal bands in multiple sclerosis. Acta Neurol Scand 113 (2006) 125-131
29. Muller F.A., Hanny P.E., Wichmann W., et al. Cerebrospinal fluid immunoglobulins and multiple sclerosis. Correspondence with magnetic resonance imaging and visually evoked potential changes. Arch Neurol 46 4 (Apr 1989) 367-371
30. Baumhefner R.W., Tourtellotte W.W., Syndulko K., et al. Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis. Arch Neurol 47 1 (Jan 1990) 19-26
31. Bartoloni S., Inzitari D., Castagnoli A., et al. Correlation of isotopic cisternographic patterns in multiple sclerosis with CSF IgG values. Ann Neurol 12 5 (Nov 1982) 486-489
32. Brown. Ellis Horwood Chichester 1986;ch.14:188-203.
33. Marrosu M.G., Murru M.R., Costa G., et al. Sardinian multiple sclerosis is associated with HLA-DR4. Neurology 38 (1988) 1749-1753
34. Rudick R.A., Cookfair D.L., Simonian N.A., et al. Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFN beta-1a) for relapsing multiple sclerosis. J Neuroloimmunol 93 (1999) 8-14
35. Sellebjerg F. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. Tissue Antigens 55 (2000) 312-318
36. Zu X.H., and McFarlin D.E. Oligoclonal bands in CSF: twins with MS. Neurology 34 (1984) 769-774
37. Freedman M.S., and Atkins H.L. Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS. Neurology 62 2 (2004) 168-169
38. Saiz A., Carreras E., Berenguer J., et al. MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS. Neurology 56 8 (Apr 24 2001) 1084-1089